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TIRADSPurpose: To compare between TIRADS and thyroid ultrasound classification system pro-
posed by Kim and his colleagues.
Methods and materials: Prospective analysis of ultrasound and power Duplex images of 450
patients with thyroid gland disease was conducted. The thyroid lesions were categorized
into 5 groups: TIRADS 1, Normal thyroid gland; TIRADS 2, benign in aspects; TIRADS 3,
probably benign aspects; TIRADS 4A, low suspicious aspects; TIRADS 4B & TIRADS 5, high
suspicious aspects. Next, the detected nodules in 350 patients were divided into solid and
partially cystic nodules and rated according to Kim et al., classification. The final diagnosis
was done by biopsy (n = 370) and clinical follow-up (n = 80). Statistical analysis in compar-
ison with cytopathological findings was calculated.
Results: The odds ratio (OR) was 7 for TIRADS 5, 2 for TIRADS 4B, 0.67 for TIRADS 4A, 0.2 for
TIRADS 3 and 0.01 for TIRADS 1 & 2. The PPV of malignancy rises gradually from 0% for
TIRADS 1 & 2 to 6.7% for TIRADS 3 & 4A to 20% for TIRADS 4B and reaches 67% for
TIRADS 5. TIRADS 5 showed 100% sensitivity, 86% specificity and 89% accuracy.
Conclusion: TIRADS classification is reliable, easier and simpler than other classification
system for reporting. It has higher sensitivity for prediction of thyroid malignancy.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by
Elsevier. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ultrasound criteria to differentiate between benign and
malignant nodules of thyroid gland have been the point of
research in many scientific papers; many of the published
papers proved that ultrasound is highly sensitive but less
specific in detection of malignant thyroid nodules [9,10].
Ultrasound features for prediction of malignancy
include hypoechogenicity, microcalcifications, taller than
wide shape, irregular or microlobulated margins and
increased intranodular vascularity [2,3].Dubitable nodules will require fine-needle aspiration
cytology (FNAC). Selection of nodules for FNAC is still con-
fusing for clinicians and radiologists as the categorization
of the same thyroid nodule may be differed according to
the used ultrasound classification system [11].
A practical thyroid imaging reporting and data system
(TIRADS) for thyroid nodules have been recently proposed
to classify nodules of thyroid gland and to solve the prob-
lem of nodule selection for FNAC [7].
TIRADS is a classification made by a multidisciplinary
team, recently published in the JCEM (Journal of Clinical
Endocrinology & Metabolism) [3], and the original idea
was to adapt the BI-RADS concept (Breast Imaging Report-
ing and Data System) from the ACR (American College of
Radiology) [1], to thyroid pathology.
Fig. 1. TIRADS classification algorithm [9].
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and reliable categorization model until the modified Russ
TIRADS categorizationhasbeenproposed in2013, Fig. 1 [12].Fig. 2. Algorithm for thyroid ultrasound baseKim et al. [5] proposed thyroid ultrasound based classi-
fication system to classify thyroid nodules depending on
the type of thyroid nodules whether they are partially cys-
tic or solid nodules [6] as shown in Fig. 2, Tables 1 and 2.
2. Aim of the work
The aim of this work was to detect which of both clas-
sification systems (TIRADS and thyroid ultrasound based
classification system proposed by Kim et al. [5]) is more
reliable, reproducible and accurate.
2.1. Patients & methods
2.1.1. Patients
From January 2013 to June 2014 series of 450 patients
(350 females and 100 males) with age range between 10
and 70 years (mean 38.7 ± 15.7 SD) underwent thyroid
ultrasound. The study was approved by our institution’s
ethics committee and all patients gave their informed con-
sent before inclusion in the study. The inclusion criteria
were neck swelling in 150 patients, palpable mass in 200
patients and abnormal thyroid function in 100 patients.
Patients with multiple thyroid nodules were excluded
from this study.
Thyroid Ultrasound: ultrasound examination of the
neck was done by using a 12.5 MHz linear-array trans-
ducer on a Toshiba Xario 200 system. Neck ultrasoundd classification system (kim et al. [5]).
Table 1
Ultrasound criteria of solid thyroid nodule.
Benign features Borderline features Malignant features
 Ovoid shape
 Isoechogenicity
 A smooth margin
 Peripheral
vascularity
 Hypoechogenicity
 centrally predominant vascularity
 Macrocalcifications (eggshell,
intranodular)
 Marked hypoechogenicity
 A spiculated margin
 Microcalcifications
 Taller-than-wide shape
 Associated cervical lymphadenopathy with intranodal cystic components or
microcalcifications
Table 2
Ultrasound criteria for partially cystic thyroid nodules.
Benign features Malignant features
 A concentric configuration or eccentric with a blunt angle
 A smooth free margin
 Peripheral or no vascularity
 A spongiform appearance or daughter cysts within the solid
component
 Intranodular comet-tail artifact
 Isoechogenicity
 An eccentric configuration of the main solid or cystic component with an acute
angle
 Microcalcifications
 Macrolobulation or irregularity of the free margin
 Perinodular infiltration
 A centripetal vascularity in the pedicle
 Associated cervical lymphadenopathy with intranodal cystic components or
microcalcifications
Fig. 3. TIRADs 1: (A and B) shows transverse and longitudinal scan of normal RT and Lt thyroid lobes, no evidences of masses, nodules or cysts are seen. No
evidences of enlarged neck lymph nodes are noted. (C) Color Doppler US: revealed average normal vascularity of the gland.
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position, with the neck slightly extended by placing a pil-
low under the patient’s shoulders. The scanning protocol
in our study includes scanning of thyroid gland and cervi-
cal lymph nodes in both transverse and longitudinal planes
by B–mode (brightness mode), CCDI (Color-coded Doppler
imaging) and PDI (Power Doppler imaging), with the use ofrepresentative Digital Imaging and Communications in
Medicine images.
2.2. Image analysis
Ultrasound and power Doppler images were analyzed.
We did not know the other clinical and final pathological
1376 G. Albair Ashamallah, M.A. EL-Adalany / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1373–1384reports. The thyroid nodules detected in this study were
analyzed according to their type (solid, cystic or mixed),
echogenicity, margins, shape and evidence of calcifications.
The margin of the nodules may be circumscribed and also
nodules may have lobulated or irregular margins. Accord-
ing to the echogenicity, nodules may be ‘‘hyperechoic”,
‘‘isoechoic”, ‘‘hypoechoic” and ‘‘marked hypoechoic”.
When calcifications were present they were classified as
microcalcifications (<3 mm) and macrocalcifications (Cal-
cific foci more than 3 mm with acoustic shadowing).
According to the shape, nodules were divided into ‘‘taller
than wide” and ‘‘wider than tall”. For mixed nodule, the
solid component was classified as concentric, eccentric
with blunt angle or acute angle. Vascularity was classified
as absent, peripheral or central. When enlarged cervical
lymph nodes were present they were categorized as
benign or malignant according to their shape and hilum.
Categorization of each nodule to a TIRADS was from 1 to
5: TIRADS1 normal thyroid gland; TIRADS 2 thyroid glandFig. 4. TIRADs 2: (A) Shows transverse and longitudinal scan of average size Rt
multiple small cysts inside (spongiform cyst) measured about (1  1.4 cm) as sh
thyroid lobe measured about (1  1.8  3.5 cm). It displayed normal homog
calcifications are seen. (C) Shows average thickness isthmus measured about (0.5
masses, nodules or cysts are seen. (E) Color Doppler US revealed average normal
PCTN FNAC result: colloid nodular goiter.has a simple cyst, spongiform cyst, isolated macrocalcifica-
tion, diffuse hypoechogenic enlarged thyroid gland. TIR-
ADS 3 has isoechogenic or hyperechogenic nodule and
has no high suspicious US features. TIRAD 4(A) has moder-
ately hypoechogenic and has no high suspicious US fea-
tures. TIRAD 4(B) has 1 or 2 high suspicious US features
and no adenopathy. TIRADS 5 has P3 high suspicious US
features and/or adenopathy (Fig. 1).
Then 350 nodules were classified into solid (n = 287)
and partially cystic nodules (n = 63) and each nodule
was categorized according to thyroid ultrasound
based classification system proposed by kim and his
colleagues.
According to the thyroid ultrasound based classification
system, solid thyroid nodules were classified into the fol-
lowing: benign, probably benign, borderline, possibly
malignant, or malignant. Partially cystic thyroid nodules
were classified into benign, probably benign, possibly
malignant, or malignant Fig. 2, Tables 1 and 2.thyroid lobe. It showed a large well-defined oval isoechoic nodule with
own in (D). (B) Shows transverse and longitudinal scan of average size Lt
enous parenchymal echogenicity. No focal masses, nodules, cysts or
cm) and normal homogenous parenchymal echopattern. No evidences of
vascularity of the gland. Thyroid ultrasound classification system: benign
Fig. 5. TIRADs (3): (A) Shows transverse and longitudinal scan of enlarged Rt thyroid lobe measured about (3.4  2.6  4.5 cm), It displayed normal
homogenous parenchymal echogenicity. No focal masses, nodules, cysts or calcifications are seen. (B) Shows transverse and longitudinal scan of enlarged Lt
thyroid lobe about (2.8  3  4 cm). It showed a large well-defined isoechoic nodule, measured about (1.95  1.9 cm) as shown in (D). (C) Enlarged isthmus
measured about 1.3 cm. Normal homogenous parenchymal echopattern. No evidences of masses, nodules or cysts are seen. (E) Rt upper deep cervical L.Ns
with preserved shape and hilum measured about 1  .5 cm. (F) Color Doppler US revealed increased thyroid vascularity and perinodular vascularity.
Thyroid ultrasound based classification system: solid benign nodule FNAC result: colloid nodular goiter.
Fig. 6. TIRADs (4A): (A) Shows transverse and longitudinal scan of average size Rt thyroid lobe about 18.6  15  32.8 mm. It displayed normal
homogenous parenchymal echogenicity. No focal masses, nodules, cysts or calcifications are seen. (B) Shows transverse and longitudinal scan of average
size Lt thyroid lobe about 15.9  22  35.2 mm. It showed a well defined mild hypoechoic nodule measure about 1.2  1.4 cm as shown in (D). (C) Shows
normal thickness isthmus measured about 5 mm, normal homogenous parenchymal echopattern. No evidences of masses, nodules or cysts are seen. (E)
Lower deep cervical L.N measure about 14  5.4 mm with preserved shape and hilum. Thyroid ultrasound based classification system: borderline solid
nodule FNAC result: follicular adenoma.
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US guided FNAC was done by using a 20 gauge needle
attached to a 10 ml disposable plastic syringe and then
the aspirated tissue was sent for pathological evaluation.
Multiple FNACs were obtained from the same thyroid
nodule and were sent for pathological evaluation. This
was done to be sure from the results of FNAC.
The final diagnosis was done by FNAC in 273 cases,
excisional biopsy in 97 patients and follow-up in 80 cases.2.3. Statistical analysis
The statistical analysis of data was done by using SPSS
program (Statistical package for social science version
20). Univariate analysis was used to calculate the Odds
ratios (ORs) with 95% confidence intervals (CIs) of each
TIRADS were calculated. All ORs were standardized to
make the scores approach an integral. The lowest value
was 0, and this means that TIRADS type could not referring
to the malignancy. The sensitivity, specificity, accuracy
positive and negative predictive values of TIRADS system
were calculated. OR, sensitivity, specificity, positive and
negative predictive values of thyroid ultrasound basedFig. 7. TIRADs (4A) (A) Showed transverse and longitudinal scan of mild enlarge
hypoechoic nodule measure about (19  24 mm) as shown in (D). (B) Showed
(2.8  2.5  3.7 cm). It showed a well defined oval hypoechoic nodule measure
(7 mm), normal homogenous parenchymal echopattern. No evidences of masse
vascularity and slightly intranodular vascularity. Thyroid ultrasound based clas
carcinoma.classification system were calculated for all categories of
solid and partially cystic thyroid nodules in comparison
with cytopathological results independently.3. Results
Thyroid ultrasound was performed in 450 patients (350
females and 100 males), and their age ranged between 10
and 70 years with a mean of 38.7 ± 15.7 SD. Patients were
evaluated because of neck swelling in 150 patients, palpa-
ble mass in 200 patients and abnormal thyroid function in
100 patients.
The final diagnosis was done by FNAC in 273 cases,
excisional biopsy in 97 patients and follow-up in 80 cases.
In this study 80 patients had normal thyroid gland (Fig. 3),
diffuse goiter was detected in 10 patients (2.2%), sub acute
thyroiditis was detected in 10 patients (2.2%), the most
common pathology was colloid nodular goiter (Figs. 4
and 5), and it was detected in 120 patients and accounts
for 26.7% of cases. Thyroiditis was detected in 40 patients
(8.9%). Follicular adenoma (Fig. 6) was detected in 40
patients (8.9%). Follicular carcinoma (Figs. 7 and 9) was
detected in 40 patients (8.9%). Papillary carcinomad Rt thyroid lobe about (2.6  3.4  3.8 cm). It showed a well defined oval
transverse and longitudinal scan of average size Lt thyroid lobe about
about (14  16 mm) as shown in (E). (C) Showed enlarged isthmus about
s, nodules or cysts are seen. (F) Doppler US revealed marked perinodular
sification system: possibly malignant solid nodule FNAC result: follicular
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noma was detected in 10 patients (2.2%). Poorly differenti-
ated carcinoma was detected in 10 patients (2.2%)
(Table 3).
The detected thyroid nodules were assessed according
to their composition, echogenicity, shape, margins and
the presence of calcifications. In this study, we detected
287 solid thyroid nodules, 173 of them were benign and
114 were malignant. 63 nodules were mixed, 26 of them
were benign and 37 were malignant. According to the
echogenicity of the nodules, we detect 129 hyperechoic
nodules, 100 out of them were benign and remaining 29
were malignant. 80 nodules were isoechoic, 66 out of them
were benign and the remaining 14 nodules were malig-
nant. 63 nodules were hypoechoic, 28 of them were benign
and 35 were malignant. Also we detected 78 markedly
hypoechoic nodules, 5 out of them were benign and the
remaining 73 nodules were malignant. According to the
shape of the nodules, we had 175 nodules with their shape
was taller than wider, 73 out of them were benign and the
remaining 102 nodules were malignant. Another 175 were
detected with their shape was wider than taller, 126 were
benign and 49 were malignant. According to the margins,
167 nodules with well defined margins were detected,
145 were benign and the remaining 22 nodules were
malignant. 105 nodules were with irregular border, 21
out of them were benign and the remaining 84 nodules
were malignant. 78 nodules with lobulated margins were
detected, 33 out of them were benign and the remaining
45 nodules were malignant. According to the presence of
calcification, micocalcific foci were seen in 92 nodules, 38Fig. 8. TIRADs (4B) (A) Shows transverse and longitudinal scan of average siz
homogenous parenchymal echogenicity. No focal masses, nodules, cysts or calci
showed ill defined oval marked hypoechoic nodule measure about 9.5  7 mmwi
normal vascularity of the gland, and the nodule had no vascularity. (F) Shows u
10  7.6 mm. Thyroid ultrasound based classification system: malignant solid nout of them were benign and the remaining 54 nodules
were malignant. Macro calcific foci were detected in 104
patients, 77 out of them were benign and the remaining
27 nodules were malignant (Table 4).
The detected thyroid nodules were categorized into 5
categories according to the Russ’s modified TI-RADS classi-
fication system. The distribution of thyroid nodules by TIR-
ADS categories was 80 cases (17.7%) in TIRADS 1 (Fig. 3), 70
(15.5%) in TIRADS 2 (Fig. 4), 110 (24.4%) in TIRADS 3
(Fig. 5), 36 (8%) in TIRADS 4A (Fig. 6 and 7), 52 (11.5%) in
TIRADS 4B (Fig. 8) and 102 (22.6%) in TIRADS 5 (Fig. 9).
The risk of malignancy calculated by the OR (95% CI) is 0
for TIRADS 1 & 2, 0.2 for TIRADS 3, 0.67 for TIRADS 4A, 2
for TIRADS 4B, and 7 for TIRADS 5 (Table 5).
Sensitivity, specificity, accuracy, positive and negative
predictive values were calculated in view of malignant
pathology for each TIRADS category. Sensitivity is 0% TIR-
ADS (1 & 2), 9.1% TIRADS (3), 25% TIRADS (4A), 60% TIRADS
(4B), 100% TIRADS (5). Specificity is 59.5% TIRADS (1),
60.5% TIRADS (2), 58.8% TIRADS (3), 65.9% TIRADS (4A),
70% TIRADS (4B), 85.7% TIRADS (5). In this study the PPV
of malignancy increases from 0% for TIRADS type 1 & type
2 to 6.7% for TIRADS type 3 & type 4A to 20% for TIRADS
type 4B to reach 67% for TIRADS type 5. In this study the
NPV was 73.3% for TI-RADS 1, 76.6% for TI-RADS 2, 66.7%
for TI-RADS 3, 90% for TI-RADS 4A, 93.3% for TI-RADS 4B
and 100% for TI-RADS 5 (Table 6).
In the second step of this study, thyroid nodules
detected in 350 cases were reclassified as solid nodules
(287 cases and represented 63% of cases) and partially cys-
tic nodules (63 cases and represent 14% of cases). 20 casese Rt thyroid lobe measured about (2  2.5  3 cm). It displayed normal
fications are seen. (B) Slightly enlarged isthmus, measured about (6 mm),
th microcalcification inside as shown in (C). (D), Color Doppler US revealed
pper deep cervical L.N with preserved shape and hilum measured about
odule FNAC result: papillary thyroid carcinoma.
Fig. 9. TIRADs (5): (A) Shows transverse and longitudinal scan of average size Rt thyroid lobe measured about (8.6  22  30 mm) and isthmus. It showed a
ill defined oval hypoechoic nodule surrounded by incomplete halo sign with microcalification inside measured about (9  13 mm) as shown in (D). (B)
Shows transverse and longitudinal scan of average size Lt thyroid lobe measured about 11  12  34 mm. It displayed normal homogenous parenchymal
echogenicity. No focal masses, nodules, cysts or calcifications are seen. (C) Average thickness isthmus about 1.5 mm and normal homogenous parenchymal
echopattern. No evidences of masses, nodules or cysts are seen. (G) Doppler US revealed both intranodular and perinodular vascularity. (H) Upper deep
cervical L.N with distorted shape and hilum measured about 14  18 mm. Thyroid ultrasound based classification system: malignant solid nodule FNAC
result: follicular carcinoma.
Table 3
Ultrasound and pathological findings of 450 patients.
Ultrasound finding Pathological finding/
patient follow up
No of
cases
Percentage
%
Normal thyroid gland -Normal thyroid 80 17.8%
Diffuse thyroid -Diffuse goiter 10 2.2%
Pathology -Subacute thyroiditis 10 2.2%
Focal thyroid -Colloid nodular
goiter
120 26.7%
Pathology -Thyroiditis 40 8.9%
-Follicular adenoma 40 8.9%
-Follicular carcinoma 40 8.9%
-Papillary carcinoma 90 20%
-Medullary
carcinoma
10 2.2%
-Poorly
differentiated
10 2.2%
Carcinoma
Total 450 100%
Table 4
Major US features and pathology results in 350 patients.
US features Pathology Total
Bg Mg
Composition
Solid 173 114 28
Mixed 26 37 63
Echogenicity
Hyperechoic 100 29 129
Isoechoic 66 14 80
Hypoechoic 28 35 63
Markedly hypoechoic 5 73 78
Shape
Taller than Wide shape 73 102 175
Wider than taller 126 49 175
Calcifications
Microcalcification 38 54 92
Macrocalcification 77 27 104
No calcification 84 70 154
Margins
Well defined 145 22 167
Irregular 21 84 105
Lobulated 33 45 78
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ADS1 category were excluded at this step.
The solid nodules were categorized as benign, probably
benign, border line, possibly malignant and malignant. In
Table 5
Number of cases in each TIRADS category, their pathological nature and risk
of malignancies.
Benign Mg Risk of Mg Total
TIRADS 1 80 0 0% 80
TIRADS 2 70 0 0% 70
TIRADS 3 103 7 6.40% 110
TIRADS 4A 26 10 27.70% 36
TIRADS 4B 18 34 65.30% 52
TIRADS 5 2 100 98.20% 102
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them were benign while the remaining 11 nodules were
proved to be malignant by pathology with a risk of malig-
nancy about 8.9%. 54 solid nodules were categorized in this
study as probably benign nodules, 43 out of them were
benign and the remaining 11 nodules were malignant with
a risk of malignancy about 20.3%. 15 nodules were catego-
rized as borderline nodules (Fig. 6), 11 out of them were
benign and the remaining 4 nodules were malignant with
a risk of malignancy about 20.6%. 30 nodules were classi-
fied as possibly malignant nodules (Fig. 7), only 4 out of
them were benign and the remaining 26 nodules were
malignant with increase in the risk of malignancy to reach
86.6%. Finally we detected 65 malignant solid thyroid nod-
ules (Figs. 8 and 9), only 3 out of them were benign while
the remaining 62 nodules were malignant with the risk of
malignancy reaches 95.4% (Table 7).
Sensitivity, specificity, accuracy, positive and negative
predictive values were calculated in view of malignant
pathology for each category. The sensitivity was 1.9% for
benign category, 6.9% for probably benign, 16.3% for possi-
bly malignant and 75% for malignant category. The speci-
ficity was 55.4% for benign category, 38.4% for probably
benign, 96.4% for possibly malignant and 97.3% for malig-
nant category. The PPV of malignancy increases from
5.7% for benign category to 13.8% for probably benign to
86.7% for possibly malignant to 98% for malignant category
(Table 8).
In this study, the partially cystic nodules were catego-
rized as benign, probably benign, possibly malignant and
malignant. In this studywedetected19benignpartially cys-
tic nodules (Fig. 4), 16 out of them were benign while the
remaining 3 nodules were proved to be malignant by
pathology with a risk of malignancy about 15%. 3 partially
cystic nodules were categorized in this study as probably
benign nodules, 2 out of themwere benign and the remain-
ing 1 nodule was proved to be malignant with a risk of
malignancy about 33%. 20 nodules were classified as possi-
bly malignant nodules, 6 out of them were benign and the
remaining 14 nodules were malignant with increase in the
risk of malignancy to reach 70%. Finally we detected 21
malignant partially cystic thyroid nodules, only 2 out of
them were benign while the remaining 19 nodules were
malignantwith the risk ofmalignancy reaches90% (Table 9).
Sensitivity, specificity, accuracy, positive and negative
predictive values were calculated in view of malignant
pathology for each category. The sensitivity was 8.1% for
benign category, 2.8% for probably benign, 37.8% for
possibly malignant and 51.4% for malignant category. The
specificity was 38.5% for benign category, 92.3% for
Table 7
Number of cases in categories of solid thyroids nodules and their
pathological nature.
Solid thyroid nodules (n = 287)
Benign Malignant Total Risk of
malignancy (%)
Benign 112 11 123 8.9
Probably Benign 43 11 54 20.3
Borderline 11 4 15 20.6
Possibly malignant 4 26 30 86.6
Malignant 3 62 65 95.4
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for malignant category. The PPV of malignancy increases
from 15.8% for benign category to 33.3% for probably
benign to 70% for possibly malignant to 91% for malignant
category (Table 10).Ta
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(4. Discussion
In this study, 3 steps were carried on: first prospective
classification of thyroid gland ultrasound findings accord-
ing to Russ’s modified TIRADS with statistical analysis of
the results of this step in view of pathological results.
The second step was to reclassify thyroid nodules detected
in 350 cases into solid (287 nodules) and partially cystic
thyroid nodules (63 nodules), and then categorization of
each nodule according to thyroid ultrasound based classifi-
cation system introduced by kim et al., followed by statis-
tical analysis of each category in view of their pathological
results. The third step was to compare statistical perfor-
mance of each categorization method.
In current study the thyroid nodular diseases repre-
sented 77.7%, This percentage is same as the estimated
incidence of 30–76% in the literature [3]. The malignant
thyroid disease represented (33.55%), and this percentage
is parallel to that of Kwak et al. who reported 36% malig-
nancy rate in their study [6].
Moifo et al., designed a study to determine whether the
Russ’s modified TIRADS classification system is reliable in
predicting thyroid cancer in a group of patients with thy-
roid nodule and compared their data with pathological
results. In their study there is increase in the risk of malig-
nancy from TIRADS 3 to 5, 2% for TIRADS3, 6% TIRADS 4A,
58% for TIRADS 4B, and 100% for TIRADS 5 [8].
In the current study, the distribution of thyroid nodules
by TIRADS categories was 80 cases (17.7%) in TIRADS 1,70
(15.5%) in TIRADS 2, 110 (24.4%) in TIRADS 3, 36 (8%) in
TIRADS 4A, 52 (11.5%) in TIRADS 4B and 102 (22.6%) in TIR-
ADS 5. The risk of malignancy calculated by the OR (95% CI)
is 0 for TIRADS 1 & 2, 0.2 for TIRADS 3, 0.67 for TIRADS 4A,
2 for TIRADS 4B, and 7 for TIRADS 5. OR significantly
increase from TIRADS 4B to 5. Our findings are within the
range obtained by Moifo and his colleagues [8].
In our study, PPV of malignancy increases from 0% for
TIRADS type 1 & type 2 to 6.7% for TIRADS type 3 & type
4A to 20% for TIRADS type 4B to reach 67% for TIRADS type
5 while Russ et al. stated that PPV for each score was 0% for
type 2, 0.25% for type 3, 6% for type 4A, 69% for type 4B and
100% for type 5 [12].
Table 9
Number of cases in each category of partially cystic thyroid nodules and
pathological nature.
Partially cystic nodule (n = 63)
Benign Malignant Total Risk of
malignancy (%)
Benign 16 3 19 15
Probably Benign 2 1 3 33
Possibly
malignant
6 14 20 70
Malignant 2 19 21 90
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positive predictive value and accuracy of the overall TIR-
ADS score were 95.7%, 61%, 99.7% and 62%, respectively
according to Russ et al. study [12]. In our study, sensitivity,
specificity, accuracy, positive and negative predictive val-
ues were calculated in view of malignant pathology for
each TIRADS category. Sensitivity is 0% TIRADS (1 & 2),
9.1% TIRADS (3), 25% TIRADS (4A), 60% TIRADS (4B), 100%
TIRADS (5). Specificity is 59.5% TIRADS (1), 60.5% TIRADS
(2), 58.8% TIRADS (3), 65.9% TIRADS (4A), 70% TIRADS
(4B), 85.7% TIRADS (5).
To safely excludemalignancy, we found a very high NPV
of 90%, 93% and 100% for scores 4A, 4B and 5 respectively,
denoting that TIRADS has high negative predictive value
for excluding thyroid cancer in the diagnosis of thyroid
nodules.
In the second step of this study, thyroid nodules
detected in 350 cases were reclassified as solid nodules
(287 cases and represented 63%) which were categorized
as benign, probably benign, border line, possibly malignant
and malignant with increase in malignancy risk from 8.9%
of benign category to 95.4% of malignant category and par-
tially cystic thyroid nodules (63 cases and represented
14%) distributed among the following categories: benign,
probably benign, possibly malignant and malignant. The
malignancy risk was 15% for benign category, 33% for prob-
ably benign, 70% for possibly malignant nodules and 90%
for malignant PCTN (partially cystic thyroid nodules). 20
cases representing diffuse thyroid lesions and 80 cases of
TIRADS1 category were excluded at this step.
The Odds ratio for estimation of malignancy risk was
higher in malignant category of both solid and partially
cystic thyroid nodules than in TIRADS 5, while diagnostic
accuracies of TIRADS 4b and 5 were higher than their sim-
ilar categories of thyroid ultrasound based classification
system.
In this study specificities of individual categories of thy-
roid ultrasound based classification system were high but
the sensitivities were lower; these findings were coping
with kim et al’s results [5]. The sensitivity, specificity and
accuracy of TIRADS 5 nodules were 100, 86 and 89% while
they were 73%, 97%, 83% for malignant solid nodule cate-
gory and 51.4%, 92%, 69% for malignant partially cystic thy-
roid nodule.
The aim of TIRADS was to improve the management of
the patients and to reduce cost-effectiveness by decreasing
the number of unnecessary fine needle aspiration cytology
(FNAC). Basic criteria were provided for nodule selection
1384 G. Albair Ashamallah, M.A. EL-Adalany / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1373–1384for FNAC for increasing benefits and decreasing costs. FNAC
is considered the best tool that helps in management of
thyroid nodules and to decide whether the detected thy-
roid nodule requires surgery or follow-up. TIRADS and
FNAC are considered as complementary procedures, and
TIRADS is considered as the only tool used for selection
of high-risk nodules that require biopsy [4].
The use of TIRADS classification system allowed to min-
imize the number of FNAC. Patients with TIRADS type 2
nodules do not require aspiration, patients with TIRADS 3
are followed up or biopsied according to surgeon’s decision
and guided by patient’s clinical state and history, while
patients who have TIRADS type 4 and TIRADS type 5 nod-
ules must be aspirated and are further operated on.
Thyroid ultrasound based classification system
included many items to memorize compared to TIRADS,
and hence TIRADS is easier to apply in daily practice for
thyroid ultrasound reporting as well as nodule selection
for biopsy.
During characterization of thyroid nodules by US, TI-
RADS is considered the way to go.
In comparing Russ’s modified TI-RADS with thyroid
ultrasound based classification system proposed by Kim
et al., we conclude that TI-RADS was similar to and was
more friendly than the thyroid ultrasound based classifica-
tion system.
The field of ultrasound characterization of thyroid nod-
ule needs further research with the emerging ultrasound
elastography techniques which may help in better charac-
terization of borderline nodule and TIRADS 3 & 4A nodules.
5. Conclusion
TIRADS involves diffuse thyroid pathologies as well as
focal nodular pathologies while thyroid ultrasound based
classification system concerns with thyroid nodules only.
 TIRADS system deals with thyroid nodule generally
while ultrasound based classification system deals with
solid nodule and partially cystic thyroid nodule (PCTN)
as separate categories.
 Statistical analysis of both systems is nearly the same. Ultrasound based classification systems have more
memorized items than TIRADs system.
 TIRADS system is simpler and easier method used for
thyroid ultrasound reporting.
 TIRADS gives surgeon an idea about the following step
(follow-up/biopsy).
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